News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

MS signs may show up in blood years before symptoms

April 22, 2024

But the researchers believe they now have a definitive sign that MS is brewing. 
Learn more

Study: Early Kesimpta treatment benefits people recently diagnosed with relapsing MS

April 18, 2024

A separate analysis of the overall study population showed similar efficacy with continuous Kesimpta treatment, which was also well-tolerated with a consistent safety profile for up to six years.
Learn more

New study probes link between Epstein Barr, MS treatments

April 09, 2024

Their findings have implications for future basic research in further understanding the biology of Epstein Barr Virus in multiple sclerosis.
Learn more

Childhood obesity linked to higher risk of developing MS in early adulthood

April 01, 2024

The researchers said that despite the limited follow-up time, their findings highlight obesity in childhood is linked to an increased susceptibility of early-onset MS more than two-fold.
Learn more

New technique maps out cellular architecture of lesions in MS

March 22, 2024

In the next step, the researchers want to use the same technique to analyze samples from more MS patients.
Learn more

Participants being sought for pilot study

March 15, 2024

This no-cost program is meant as an addition to any medical care that participants are currently receiving.
Learn more

MS drugs taken while breastfeeding may not affect child development

March 06, 2024

The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab, and ofatumumab.
Learn more

Shifting the perspective in spasticity in MS

March 04, 2024

Taking the patient viewpoint on diagnosis and treatment.
Learn more

Study offers insights into lesion formation in MS

February 28, 2024

Researchers found that microglia nodules are linked to more severe MS pathology.
Learn more

MS signs may show up in blood years before symptoms

April 22, 2024

But the researchers believe they now have a definitive sign that MS is brewing. 
Learn more

Study: Early Kesimpta treatment benefits people recently diagnosed with relapsing MS

April 18, 2024

A separate analysis of the overall study population showed similar efficacy with continuous Kesimpta treatment, which was also well-tolerated with a consistent safety profile for up to six years.
Learn more

New study probes link between Epstein Barr, MS treatments

April 09, 2024

Their findings have implications for future basic research in further understanding the biology of Epstein Barr Virus in multiple sclerosis.
Learn more

Childhood obesity linked to higher risk of developing MS in early adulthood

April 01, 2024

The researchers said that despite the limited follow-up time, their findings highlight obesity in childhood is linked to an increased susceptibility of early-onset MS more than two-fold.
Learn more

New technique maps out cellular architecture of lesions in MS

March 22, 2024

In the next step, the researchers want to use the same technique to analyze samples from more MS patients.
Learn more

Participants being sought for pilot study

March 15, 2024

This no-cost program is meant as an addition to any medical care that participants are currently receiving.
Learn more

MS drugs taken while breastfeeding may not affect child development

March 06, 2024

The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab, and ofatumumab.
Learn more

Shifting the perspective in spasticity in MS

March 04, 2024

Taking the patient viewpoint on diagnosis and treatment.
Learn more

Study offers insights into lesion formation in MS

February 28, 2024

Researchers found that microglia nodules are linked to more severe MS pathology.
Learn more

Biological tool provides understanding of the complexity of MS

February 13, 2024

New study provides an integrated view of this complex system and revealed the relationship between four biological scales: proteins, cells, tissues, and behavior.
Learn more

Highly effective therapies linked to lower risk of relapse in pediatric-onset MS

February 09, 2024

The results suggest prioritizing initial highly effective therapies in pediatric onset MS, although long-term safety studies are needed.
Learn more

Participants sought for survey about access to, affordability of MS treatment

February 07, 2024

The results of the survey will help the Multiple Sclerosis Foundation represent the needs of the MS community while advocating for access to, and affordability of, treatments.
Learn more

Study: Socioeconomic opportunity may be at root of disparities in MS outcomes

January 25, 2024

Minority women were more likely to have more advanced disease and faced greater challenges in pregnancy.
Learn more

Different pain types in MS can cause difficulty staying active

January 17, 2024

The study’s authors said there is a growing need to consider what type of pain MS patients are experiencing before giving them an exercise plan.
Learn more

Study: Genetics discovery may help in MS fight

January 12, 2024

The study’s authors note the findings mean we can now understand and seek to treat MS for what it actually is: the result of a genetic adaptation to certain environmental conditions that occurred in prehistory.
Learn more

EBV-specific T-cells play key role in development of MS

January 11, 2024

T-cells specific for EBV-infected cells are present in high numbers in the cerebrospinal fluid of people with MS at its earliest stages.
Learn more

MS progression and relapse activity in children

January 10, 2024

The findings suggest that patients with pediatric onset are less likely to exhibit progression independent of relapse activity over a decade of follow-up.
Learn more

Study finds similarity between vitamin B12 loss and MS

December 14, 2023

The findings suggest new ways to improve the treatment of MS through CNS-B12 supplementation.
Learn more


Show More News